These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 15238559)
1. Carmustine, vincristine, and prednisone in the treatment of canine lymphosarcoma. Ricci Lucas SR; Pereira Coelho BM; Marquezi ML; Franchini ML; Miyashiro SI; De Benedetto Pozzi DH J Am Anim Hosp Assoc; 2004; 40(4):292-9. PubMed ID: 15238559 [TBL] [Abstract][Full Text] [Related]
2. Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma. Lucas SR; Maranhão RC; Guerra JL; Coelho BM; Barboza R; Pozzi DH Vet Comp Oncol; 2015 Sep; 13(3):184-93. PubMed ID: 23615221 [TBL] [Abstract][Full Text] [Related]
3. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005). Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992 [TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol. Curran K; Thamm DH Vet Comp Oncol; 2016 Aug; 14 Suppl 1():147-55. PubMed ID: 26279153 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for canine lymphosarcoma. Madewell BR Am J Vet Res; 1975 Oct; 36(10):1525-8. PubMed ID: 1242622 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma. Wang SL; Lee JJ; Liao AT Vet J; 2015 Jul; 205(1):69-73. PubMed ID: 26004824 [TBL] [Abstract][Full Text] [Related]
7. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours. Rassnick KM; Bailey DB; Russell DS; Flory AB; Kiselow MA; Intile JL; Malone EK; Balkman CE; Barnard SM Vet Comp Oncol; 2010 Jun; 8(2):138-52. PubMed ID: 20579327 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic responses in dogs with lymphosarcoma and hypercalcemia. Weller RE; Theilen GH; Madewell BR J Am Vet Med Assoc; 1982 Nov; 181(9):891-3. PubMed ID: 6897239 [TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma. Khanna C; Lund EM; Redic KA; Hayden DW; Bell FW; Goulland EL; Klausner JS J Am Vet Med Assoc; 1998 Oct; 213(7):985-90. PubMed ID: 9776993 [TBL] [Abstract][Full Text] [Related]
10. Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs. Northrup NC; Gieger TL; Kosarek CE; Saba CF; LeRoy BE; Wall TM; Hume KR; Childress MO; Keys DA Vet Comp Oncol; 2009 Mar; 7(1):38-44. PubMed ID: 19222829 [TBL] [Abstract][Full Text] [Related]
11. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231 [TBL] [Abstract][Full Text] [Related]
12. Cyclic combination chemotherapy of canine lymphosarcoma. MacEwen EG; Brown NO; Patnaik AK; Hayes AA; Passe S J Am Vet Med Assoc; 1981 Jun; 178(11):1178-81. PubMed ID: 6895078 [No Abstract] [Full Text] [Related]
14. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. Taylor F; Gear R; Hoather T; Dobson J J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma. Price GS; Page RL; Fischer BM; Levine JF; Gerig TM J Vet Intern Med; 1991; 5(5):259-62. PubMed ID: 1748977 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience. Smallwood K; Tanis JB; Grant IA; Blackwood L; Killick DR; Amores-Fuster I; Elliott J; Mas A; Harper A; Marrington M; Finotello R Vet Comp Oncol; 2019 Jun; 17(2):165-173. PubMed ID: 30666777 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981). MacEwen EG; Hayes AA; Matus RE; Kurzman I J Am Vet Med Assoc; 1987 Mar; 190(5):564-8. PubMed ID: 3558097 [TBL] [Abstract][Full Text] [Related]
19. Lymphosarcoma. A comparison of extended to conservative chemotherapy. Kaufman JH; Ezdinli E; Aungst CW; Stutzman L Cancer; 1976 Mar; 37(3):1283-92. PubMed ID: 946592 [TBL] [Abstract][Full Text] [Related]
20. Histologic classification as a prognostic criterion for canine lymphosarcoma. Weller RE; Holmberg CA; Theilen GH; Madewell BR Am J Vet Res; 1980 Aug; 41(8):1310-4. PubMed ID: 6893792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]